Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2010

Open Access 01-12-2010 | Research

Resveratrol differentially modulates inflammatory responses of microglia and astrocytes

Authors: Xiaofeng Lu, Lili Ma, Lingfei Ruan, Yan Kong, Haiwei Mou, Zhijie Zhang, Zhijun Wang, Ji Ming Wang, Yingying Le

Published in: Journal of Neuroinflammation | Issue 1/2010

Login to get access

Abstract

Background

Inflammatory responses in the CNS mediated by activated glial cells play an important role in host-defense but are also involved in the development of neurodegenerative diseases. Resveratrol is a natural polyphenolic compound that has cardioprotective, anticancer and anti-inflammatory properties. We investigated the capacity of resveratrol to protect microglia and astrocyte from inflammatory insults and explored mechanisms underlying different inhibitory effects of resveratrol on microglia and astrocytes.

Methods

A murine microglia cell line (N9), primary microglia, or astrocytes were stimulated by LPS with or without different concentrations of resveratrol. The expression and release of proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1) and iNOS/NO by the cells were measured by PCR/real-time PCR and ELISA, respectively. The phosphorylation of the MAP kinase superfamily was analyzed by western blotting, and activation of NF-κB and AP-1 was measured by luciferase reporter assay and/or electrophoretic mobility shift assay.

Results

We found that LPS stimulated the expression of TNF-α, IL-1β, IL-6, MCP-1 and iNOS in murine microglia and astrocytes in which MAP kinases, NF-κB and AP-1 were differentially involved. Resveratrol inhibited LPS-induced expression and release of TNF-α, IL-6, MCP-1, and iNOS/NO in both cell types with more potency in microglia, and inhibited LPS-induced expression of IL-1β in microglia but not astrocytes. Resveratrol had no effect on LPS-stimulated phosphorylation of ERK1/2 and p38 in microglia and astrocytes, but slightly inhibited LPS-stimulated phosphorylation of JNK in astrocytes. Resveratrol inhibited LPS-induced NF-κB activation in both cell types, but inhibited AP-1 activation only in microglia.

Conclusion

These results suggest that murine microglia and astrocytes produce proinflammatory cytokines and NO in response to LPS in a similar pattern with some differences in signaling molecules involved, and further suggest that resveratrol exerts anti-inflammatory effects in microglia and astrocytes by inhibiting different proinflammatory cytokines and key signaling molecules.
Appendix
Available only for authorised users
Literature
1.
go back to reference Perry VH, Gordon S: Macrophages and microglia in the nervous system. Trends Neurosc. 1988, 11: 273-277. 10.1016/0166-2236(88)90110-5.CrossRef Perry VH, Gordon S: Macrophages and microglia in the nervous system. Trends Neurosc. 1988, 11: 273-277. 10.1016/0166-2236(88)90110-5.CrossRef
2.
go back to reference Aloisi F: The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv Exp Med Biol. 1999, 468: 123-133.CrossRefPubMed Aloisi F: The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv Exp Med Biol. 1999, 468: 123-133.CrossRefPubMed
3.
4.
go back to reference Chen Y, Swanson RA: Astrocytes and brain injury. J Cereb Blood Flow Metab. 2003, 23: 137-149. 10.1097/00004647-200302000-00001.CrossRefPubMed Chen Y, Swanson RA: Astrocytes and brain injury. J Cereb Blood Flow Metab. 2003, 23: 137-149. 10.1097/00004647-200302000-00001.CrossRefPubMed
5.
go back to reference McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM: Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001, 169: 219-230. 10.1006/exnr.2001.7688.CrossRefPubMed McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM: Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001, 169: 219-230. 10.1006/exnr.2001.7688.CrossRefPubMed
6.
go back to reference Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM: Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res. 2002, 133: 27-35. 10.1016/S0165-3806(01)00315-7.CrossRefPubMed Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM: Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res. 2002, 133: 27-35. 10.1016/S0165-3806(01)00315-7.CrossRefPubMed
7.
go back to reference Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS: NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem. 2004, 279: 1415-1421. 10.1074/jbc.M307657200.CrossRefPubMed Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS: NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem. 2004, 279: 1415-1421. 10.1074/jbc.M307657200.CrossRefPubMed
8.
go back to reference Matsumoto Y, Ohmori K, Fujiwara M: Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J Neuroimmunol. 1992, 37: 23-33. 10.1016/0165-5728(92)90152-B.CrossRefPubMed Matsumoto Y, Ohmori K, Fujiwara M: Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J Neuroimmunol. 1992, 37: 23-33. 10.1016/0165-5728(92)90152-B.CrossRefPubMed
9.
go back to reference Zeinstra E, Wilczak N, De Keyser J: Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J Neuroimmunol. 2003, 135: 166-171. 10.1016/S0165-5728(02)00462-9.CrossRefPubMed Zeinstra E, Wilczak N, De Keyser J: Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J Neuroimmunol. 2003, 135: 166-171. 10.1016/S0165-5728(02)00462-9.CrossRefPubMed
10.
go back to reference McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988, 38: 1285-1291.CrossRefPubMed McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988, 38: 1285-1291.CrossRefPubMed
11.
go back to reference Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH: Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci. 2003, 18: 2731-2742. 10.1111/j.1460-9568.2003.03014.x.CrossRefPubMed Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH: Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci. 2003, 18: 2731-2742. 10.1111/j.1460-9568.2003.03014.x.CrossRefPubMed
12.
go back to reference Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D: Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989, 24: 173-182. 10.1016/0165-5728(89)90115-X.CrossRefPubMed Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D: Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989, 24: 173-182. 10.1016/0165-5728(89)90115-X.CrossRefPubMed
13.
go back to reference Merrill JE, Chen IS: HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 1991, 5: 2391-2397.PubMed Merrill JE, Chen IS: HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 1991, 5: 2391-2397.PubMed
14.
go back to reference Bhat KP, Pezzuto JM: Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci. 2002, 57: 210-229. 10.1111/j.1749-6632.2002.tb02918.x.CrossRef Bhat KP, Pezzuto JM: Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci. 2002, 57: 210-229. 10.1111/j.1749-6632.2002.tb02918.x.CrossRef
15.
go back to reference Das DK, Maulik N: Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006, 6: 36-47. 10.1124/mi.6.1.7.CrossRefPubMed Das DK, Maulik N: Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006, 6: 36-47. 10.1124/mi.6.1.7.CrossRefPubMed
16.
go back to reference Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y, Yologlu S: Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci. 2007, 14: 256-260. 10.1016/j.jocn.2005.12.010.CrossRefPubMed Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y, Yologlu S: Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci. 2007, 14: 256-260. 10.1016/j.jocn.2005.12.010.CrossRefPubMed
17.
go back to reference Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE: Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int. 2009, 54: 111-118. 10.1016/j.neuint.2008.10.008.PubMedCentralCrossRefPubMed Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE: Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int. 2009, 54: 111-118. 10.1016/j.neuint.2008.10.008.PubMedCentralCrossRefPubMed
18.
go back to reference de la Lastra CA, Villegas I: Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005, 49: 405-430. 10.1002/mnfr.200500022.CrossRefPubMed de la Lastra CA, Villegas I: Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005, 49: 405-430. 10.1002/mnfr.200500022.CrossRefPubMed
19.
go back to reference Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TF: Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide. 2003, 9: 64-76. 10.1016/j.niox.2003.09.005.CrossRefPubMed Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TF: Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide. 2003, 9: 64-76. 10.1016/j.niox.2003.09.005.CrossRefPubMed
20.
go back to reference Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF: Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005, 5: 185-193. 10.1016/j.intimp.2004.08.008.CrossRefPubMed Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF: Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005, 5: 185-193. 10.1016/j.intimp.2004.08.008.CrossRefPubMed
21.
go back to reference Candelario-Jalil E, de Oliveira AC, Gräf S, Bhatia HS, Hüll M, Muñoz E, Fiebich BL: Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation. 2007, 4: 25-10.1186/1742-2094-4-25.PubMedCentralCrossRefPubMed Candelario-Jalil E, de Oliveira AC, Gräf S, Bhatia HS, Hüll M, Muñoz E, Fiebich BL: Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation. 2007, 4: 25-10.1186/1742-2094-4-25.PubMedCentralCrossRefPubMed
22.
go back to reference Kim YA, Kim GY, Park KY, Choi YH: Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J Med Food. 2007, 10: 218-24. 10.1089/jmf.2006.143.CrossRefPubMed Kim YA, Kim GY, Park KY, Choi YH: Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J Med Food. 2007, 10: 218-24. 10.1089/jmf.2006.143.CrossRefPubMed
23.
go back to reference Xu J, Drew PD: 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2006, 171: 135-144. 10.1016/j.jneuroim.2005.10.004.PubMedCentralCrossRefPubMed Xu J, Drew PD: 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2006, 171: 135-144. 10.1016/j.jneuroim.2005.10.004.PubMedCentralCrossRefPubMed
24.
go back to reference Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P: Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 1993, 7: 255-262. 10.1002/glia.440070309.CrossRefPubMed Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P: Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 1993, 7: 255-262. 10.1002/glia.440070309.CrossRefPubMed
25.
go back to reference Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS: 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 2005, 19: 395-397.PubMed Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS: 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 2005, 19: 395-397.PubMed
26.
go back to reference Zhu J, Wang O, Ruan L, Hou X, Cui Y, Wang JM, Le Y: The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol. 2009, 9: 1126-1130. 10.1016/j.intimp.2009.05.002.CrossRefPubMed Zhu J, Wang O, Ruan L, Hou X, Cui Y, Wang JM, Le Y: The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol. 2009, 9: 1126-1130. 10.1016/j.intimp.2009.05.002.CrossRefPubMed
27.
go back to reference Zhou YL, Snead ML: Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene. J Biol Chem. 2000, 275: 12273-12280. 10.1074/jbc.275.16.12273.CrossRefPubMed Zhou YL, Snead ML: Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene. J Biol Chem. 2000, 275: 12273-12280. 10.1074/jbc.275.16.12273.CrossRefPubMed
28.
29.
go back to reference Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000, 119: 1209-1218. 10.1053/gast.2000.19458.CrossRefPubMed Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000, 119: 1209-1218. 10.1053/gast.2000.19458.CrossRefPubMed
30.
go back to reference Hahm ER, Cheon G, Lee J, Kim B, Park C, Yang CHL: New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett. 2002, 184: 89-96. 10.1016/S0304-3835(02)00170-2.CrossRefPubMed Hahm ER, Cheon G, Lee J, Kim B, Park C, Yang CHL: New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett. 2002, 184: 89-96. 10.1016/S0304-3835(02)00170-2.CrossRefPubMed
31.
go back to reference Calderoni AM, Biaggio V, Acosta M, Oliveros L, Mohamed F, Giménez MS: Cadmium exposure modifies lactotrophs activity associated to genomic and morphological changes in rat pituitary anterior lobe. Biometals. 2010, 23: 135-143. 10.1007/s10534-009-9274-8.CrossRefPubMed Calderoni AM, Biaggio V, Acosta M, Oliveros L, Mohamed F, Giménez MS: Cadmium exposure modifies lactotrophs activity associated to genomic and morphological changes in rat pituitary anterior lobe. Biometals. 2010, 23: 135-143. 10.1007/s10534-009-9274-8.CrossRefPubMed
32.
go back to reference Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature. 2000, 406: 782-787. 10.1038/35021228.CrossRefPubMed Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature. 2000, 406: 782-787. 10.1038/35021228.CrossRefPubMed
33.
go back to reference Ortega-Gutierrez S, Molina-Holgado E, Guaza C: Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia. 2005, 52: 163-168. 10.1002/glia.20229.CrossRefPubMed Ortega-Gutierrez S, Molina-Holgado E, Guaza C: Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia. 2005, 52: 163-168. 10.1002/glia.20229.CrossRefPubMed
34.
go back to reference Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005, 50: 235-246. 10.1002/glia.20173.CrossRefPubMed Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005, 50: 235-246. 10.1002/glia.20173.CrossRefPubMed
35.
go back to reference Li Y, Liu L, Barger SW, Mrak RE, Griffin WS: Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001, 66: 163-170. 10.1002/jnr.1208.PubMedCentralCrossRefPubMed Li Y, Liu L, Barger SW, Mrak RE, Griffin WS: Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001, 66: 163-170. 10.1002/jnr.1208.PubMedCentralCrossRefPubMed
36.
go back to reference Uesugi M, Nakajima K, Tohyama Y, Kohsaka S, Kurihara T: Nonparticipation of nuclear factor kappa B (NFkappaB) in the signaling cascade of c-Jun N-terminal kinase (JNK)- and p38 mitogen-activated protein kinase (p38MAPK)-dependent tumor necrosis factor alpha (TNFalpha) induction in lipopolysaccharide (LPS)-stimulated microglia. Brain Res. 2006, 1073-1074: 48-59. 10.1016/j.brainres.2005.12.043.CrossRefPubMed Uesugi M, Nakajima K, Tohyama Y, Kohsaka S, Kurihara T: Nonparticipation of nuclear factor kappa B (NFkappaB) in the signaling cascade of c-Jun N-terminal kinase (JNK)- and p38 mitogen-activated protein kinase (p38MAPK)-dependent tumor necrosis factor alpha (TNFalpha) induction in lipopolysaccharide (LPS)-stimulated microglia. Brain Res. 2006, 1073-1074: 48-59. 10.1016/j.brainres.2005.12.043.CrossRefPubMed
37.
go back to reference Jeng KC, Hou RC, Wang JC, Ping LI: Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005, 97: 101-106. 10.1016/j.imlet.2004.10.004.CrossRefPubMed Jeng KC, Hou RC, Wang JC, Ping LI: Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005, 97: 101-106. 10.1016/j.imlet.2004.10.004.CrossRefPubMed
38.
go back to reference Bhat NR, Zhang P, Lee JC, Hogan EL: Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 1998, 18: 1633-1641.PubMed Bhat NR, Zhang P, Lee JC, Hogan EL: Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 1998, 18: 1633-1641.PubMed
39.
go back to reference Pahan K, Sheikh FG, Khan M, Namboodiri AM, Singh I: Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem. 1998, 273: 2591-2600. 10.1074/jbc.273.5.2591.CrossRefPubMed Pahan K, Sheikh FG, Khan M, Namboodiri AM, Singh I: Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem. 1998, 273: 2591-2600. 10.1074/jbc.273.5.2591.CrossRefPubMed
40.
go back to reference Pawate S, Bhat NR: C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform. Antioxid Redox Signal. 2006, 8: 903-909. 10.1089/ars.2006.8.903.CrossRefPubMed Pawate S, Bhat NR: C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform. Antioxid Redox Signal. 2006, 8: 903-909. 10.1089/ars.2006.8.903.CrossRefPubMed
41.
go back to reference Kundu JK, Surh YJ: Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res. 2004, 55: 65-80.CrossRef Kundu JK, Surh YJ: Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res. 2004, 55: 65-80.CrossRef
42.
go back to reference Kundu JK, Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269: 243-261. 10.1016/j.canlet.2008.03.057.CrossRefPubMed Kundu JK, Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269: 243-261. 10.1016/j.canlet.2008.03.057.CrossRefPubMed
43.
go back to reference Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23: 2369-2380. 10.1038/sj.emboj.7600244.PubMedCentralCrossRefPubMed Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23: 2369-2380. 10.1038/sj.emboj.7600244.PubMedCentralCrossRefPubMed
44.
go back to reference Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, Peng Y, You M: Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009, 296: G1047-G1053. 10.1152/ajpgi.00016.2009.PubMedCentralCrossRefPubMed Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, Peng Y, You M: Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009, 296: G1047-G1053. 10.1152/ajpgi.00016.2009.PubMedCentralCrossRefPubMed
45.
go back to reference Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH: Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol. 2005, 175: 3339-3346.CrossRefPubMed Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH: Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol. 2005, 175: 3339-3346.CrossRefPubMed
46.
go back to reference Young MR, Yang HS, Colburn NH: Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med. 2003, 9: 36-41. 10.1016/S1471-4914(02)00009-6.CrossRefPubMed Young MR, Yang HS, Colburn NH: Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med. 2003, 9: 36-41. 10.1016/S1471-4914(02)00009-6.CrossRefPubMed
47.
go back to reference Kundu JK, Shin YK, Surh YJ: Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol. 2006, 72: 1506-1515. 10.1016/j.bcp.2006.08.005.CrossRefPubMed Kundu JK, Shin YK, Surh YJ: Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol. 2006, 72: 1506-1515. 10.1016/j.bcp.2006.08.005.CrossRefPubMed
Metadata
Title
Resveratrol differentially modulates inflammatory responses of microglia and astrocytes
Authors
Xiaofeng Lu
Lili Ma
Lingfei Ruan
Yan Kong
Haiwei Mou
Zhijie Zhang
Zhijun Wang
Ji Ming Wang
Yingying Le
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2010
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-7-46

Other articles of this Issue 1/2010

Journal of Neuroinflammation 1/2010 Go to the issue